Items Tagged ‘Dr. Richard Weinshilboum’

December 17, 2021

Mayo Clinic researchers use AI, biomarkers to personalize rheumatoid arthritis treatment

By Susan Murphy Susan Murphy (@susanmurphy)

By Emily Blahnik Treatment options for rheumatoid arthritis have often relied on trial and error. Now Mayo Clinic researchers are exploring the use of artificial intelligence (AI) and pharmacogenomics to predict how patients will respond to treatments, and to personalize care. Findings were published in Arthritis Care & Research. The study focused on predicting the […]

View full entry

Tags: #Dr. Arjun Athreya, center for individualized medicine, Dr. Liewei Wang, Dr. Richard Weinshilboum, Rheumatoid Arthritis

April 13, 2021

Mayo study examines how Latino participants experience genomic medicine

By Colette Gallagher Colette Gallagher (@colettegallagher)

View full entry

Tags: #Mayo Clinic Biomedical Ethics Research Program, Annual Clinical Genetics Meeting, Dr. Richard Sharp, Dr. Richard Weinshilboum, mayo clinic, Mayo Clinic Center for Individualized Medicine

June 10, 2019

Meet William Bobo, M.D. – taking the guesswork out of finding the right depression therapy

By Sharon Rosen Sharon Rosen (@sharonhrosen)

Depression can touch every aspect of a person’s life – affecting the way they think, feel and behave. It is also the leading medical condition for those who complete suicide. Getting the right therapy is crucial. But for patients suffering from the disorder, finding an effective treatment often involves trial and error. That’s because it […]

View full entry

Tags: #Artificial Intelligence, #Center for Individualized Mediicine, #Dr. Arjun Athreya, #Dr. William Bobo, #individualized mediicne, #Mayo Clinic and Illinois Alliance for Technology-Based Healthcare, #mood disorders, #predictive algorithm, #selective serotonin reuptake inhibitors, #targeted therapies, #Treatment response, antidepressants

October 23, 2018

Mayo Clinic research combines genetics and psychiatry to seek biomarkers for precise alcohol abuse therapies

By Susan Buckles Susan Buckles (@susanbuckles)

Mayo Clinic research is bringing together knowledge of psychiatry, genetics, metabolomics, pharmacogenomics and artificial intelligence to seek biological markers associated with alcohol use disorder and treatment response. Finding the molecular drivers of alcohol use disorder commonly known as alcoholism, could help predict who is most likely to develop this disorder and who might respond to […]

View full entry

Tags: Alcohol use disorder, Alcoholism, Alcoholism Recovery, Dr. Richard Weinshilboum, Dr. Victor Karpyak, Hazelden Betty Ford Foundation, Mayo Clinic Center for Individualized Medicine

September 17, 2018

CIMCON18 — how genomics discovery is transforming individualized care and the path forward

By Sharon Rosen Sharon Rosen (@sharonhrosen)

Mining information deeper than genomics, understanding factors linked to disease, analyzing big data, and addressing the challenges of bringing all this information together to advance patient care – these were some of the themes featured at the Individualizing Medicine Conference: Advancing Care through Genomics held in Rochester, Minnesota, Sept. 12-13, and sponsored by the Mayo […]

View full entry

Tags: #All of Us Research Program biobank, #CAR T-cell therapy, #CIMCon18, #Dr. Eric Green, #Dr. Gabriel Krestin, #Dr. Manolis Kellis, #Dr. Michael Berger, #Dr. Nancy Cox, #Dr. Yi Lin, #Genomic data, All of Us Research Program, center for individualized medicine

June 25, 2018

Research suggests genetics are key in treating night sweats

By Susan Buckles Susan Buckles (@susanbuckles)

Article by Heather Carlson Women going through menopause know all too well the discomfort associated with night sweats. Hormone therapy is often used to prevent night sweats. But finding the right dose of estrogen can be tricky, with some women needing more estrogen than others to get relief. Why the difference in how women respond […]

View full entry

Tags: Dr. Ann Moyer, Dr. Richard Weinshilboum, Dr. Virginia Miller, Mayo Clinic Center for Individualized Medicine, Mayo Clinic Women's Health Research Center, Menopause, Night sweats, pharmacogenomics

June 12, 2018

Harnessing the power of big data to uncover genetic risk for disease

By Sharon Rosen Sharon Rosen (@sharonhrosen)

There is no single gene that causes diabetes, bipolar disorder or Alzheimer’s disease, but there are genes linked to conditions that may occur before a patient eventually develops these disorders. What if researchers could identify individuals whose genetic makeup puts them at risk for developing disease so that physicians could intervene sooner and provide more […]

View full entry

Tags: #bipolar disorder, #CIMCon18, #computational genetics, #diabetes, #Dr. Nany Cox, #genetic data analysis, #Individualizing Medicine 2018, #Vanderbilt University Biobank, Alzheimer’s disease, Biobank, center for individualized medicine, DNA Sequencing

April 16, 2018

15 ways genomics is impacting our lives: Genomic literacy and pharmacogenomics

By Susan Buckles Susan Buckles (@susanbuckles)

To apply important genomic research at the point of care, medical providers and patients must first understand it. That fact spotlights the need for “Genomics 101” type of education to help the medical community keep up with newest discoveries. Genomic literacy – explaining scientific findings in understandable terms – is one goal of the ‘15 […]

View full entry

Tags: 15for15, DNA Day 18, DNA Sequencing, Dr. Richard Weinshilboum, Dr. Timothy Curry, Genetic Testing, Genetics, Genomic literacy, genomics, GLEE initiative, Human Genome Project, individualized medicine

March 20, 2018

Mayo’s RIGHT 10K – moving pharmacogenomics into everyday clinical practice

By Sharon Rosen Sharon Rosen (@sharonhrosen)

After nearly half a century of research, Mayo Clinic is a leader in moving pharmacogenomics into clinical practice. This year pharmacogenomics test results for 10,000 Mayo Clinic patients, all participants in the RIGHT 10K study, are being added to the electronic health record. “I’ve spent my career exploring pharmacogenomics – how a person’s genetics affect […]

View full entry

Tags: #CIMCon18, #DNA sequencing tests, #Dr. Paul Takahashi, #drug-gene interactions, #pharmacogenomic testing, #RIGHT 10K, center for individualized medicine, DNA, Dr. Richard Weinshilboum, genomics, mayo clinic, medical research

November 28, 2017

From pharmacogenomics to pharmaco-omics – individualized care for every patient

By Sharon Rosen Sharon Rosen (@sharonhrosen)

When prescribing a medication for you, your physician considers many factors, including your age, sex, weight and current health conditions. Now, add to that list your unique genetic characteristics. Your genes affect the way you respond to medications. Pharmacogenomics is a term used to describe the use of genomic information to help select the right […]

View full entry

Tags: #drug-gene interactions, #pharmacogenomics testing, #RIGHT 10K study, center for individualized medicine, Dr. Liewei Wang, Dr. Richard Weinshilboum, individualized medicine, mayo clinic, Mayo Clinic Proceedings, pharmacogenomics

Contact Us · Privacy Policy